Clinical Relevance of Faecal Calprotectin Level in Infantile Colic: A Cross-sectional Survey

Document Type: Original Article

Authors

1 Pediatric Ward, Amir Al-Momenin Hospital, Zabol University of Medical Sciences, Zabol, Iran

2 Zabol University of Medical Sciences

3 Zabol University of Medical Sciences, Zabol, Iran

4 Faculty of Allied Medical Sciences, Zabol University of Medical Sciences, Zabol, Iran

Abstract

Background: There is limited knowledge on the potential applicability of fecal calprotectin (f-CP) as an inflammatory screening parameter in infantile colic (IC). This study aimed to evaluate f-CP in neonates with IC as a useful diagnostic indicator regarding this condition.
Methods: The present study was conducted on 100 cases, including 50 newborns with IC and 50 non-colicky neonates. The diagnosis of IC was fulfilled by the Wessel Criteria. The level of f-CP was determined by a specific enzyme-linked immunosorbent assay kit (Calprotectin ELISA, EuroImmun, Germany). The statistical analysis was performed in SPSS software (version 19).  
Results: Out of 100 neonates, 57 cases were male and 43 subjects were female. The age spectrum ranged from 19-90 days (40.4±15.9). Colicky newborns were slightly younger (P=0.06) with higher birth weight compared to the infants without colic (P<0.0001). The level of f-CP was significantly higher in colicky neonates (113.7±98.2 µg/g) than non-colicky cases (71.4±45.5 µg/g) (P=0.007). Overall, 37%, 30%, 26%, and 7% of the newborns showed f-CP levels<50, 50-100, 100-200, and >200 µg/g, respectively. There was a significant difference regarding the distribution of these f-CP categories between neonates with IC and the cases without IC (P=0.02). There were no significant correlations between the f-CP and newborn age, pregnancy age, present or birth weights, and number of pregnancies. Receiver operating characteristic analysis rendered an area under the curve of 0.642 (95% CI: 0.534-0.748) (P=0.01). At the cut-off value of 74 µg/g, f-CP showed sensitivity of 60% and specificity of 59% for the detection of IC.
Conclusion: The results of this study revealed that the f-CP might be useful in the diagnosis of the IC.

Keywords


1. Campeotto F, Butel MJ, Kalach N, Derrieux S, AubertJacquin C, Barbot L, et al. High faecal calprotectin concentrations in newborn infants. Archives of Disease in Childhood. 2004;89(4):F353-F5.

2. Aalto K, Lahdenne P, Kolho KL. Fecal calprotectin in juvenile idiopathic arthritis patients related to drug use. Pediatric Rheumatology. 2017;15.

3. Fagerberg UL, Loof L, Myrdal U, Hansson LO, Finkel Y. Colorectal inflammation is well predicted by fecal calprotectin in children with gastrointestinal symptoms. J Pediatr Gastroenterol Nutr. 2005; 40(4):450-5.

 4. Shams SF, Boskabadi H, Keramati MR, Ayatollahi H, Shakeri S, Sheikhi M, et al. Evaluation of Immature Neutrophil Ratio and Calprotectin Level for the Diagnosis of Neonatal Sepsis. Iranian Journal of Neonatology IJN. 2017;8(3):19-24.

 5. Bremner A, Roked S, Robinson R, Phillips I, Beattie M. Faecal calprotectin in children with chronic gastrointestinal symptoms. Acta Paediatrica. 2005; 94(12):1855-8.

 6. Fagerberg UL, Loof L, Lindholm J, Hansson LO, Finkel Y. Fecal calprotectin: A quantitative marker of colonic inflammation in children with inflammatory bowel disease. J Pediatr Gastroenterol Nutr. 2007; 45(4):414-20.

 7. Hukkinen M, Pakarinen MP, Merras-Salmio L, Koivusalo A, Rintala R, Kolho KL. Fecal calprotectin in the prediction of postoperative recurrence of Crohn's disease in children and adolescents. Journal of Pediatric Surgery. 2016;51(9):1467-72.

 8. Ellemunter H, Engelhardt A, Schuller K, Steinkamp G. Fecal Calprotectin in Cystic Fibrosis and Its Relation to Disease Parameters: A Longitudinal Analysis for 12 Years. J Pediatr Gastroenterol Nutr. 2017;65(4):438-42.

9. Khoshbaten M, Pishahang P, Nouri M, Lashkari A, Alizadeh M, Rostami-Nejad M. Diagnostic value of fecal calprotectin as a screening biomarker for gastrointestinal malignancies. Asian Pacific journal of cancer prevention : APJCP. 2014;15(4):1667-70.

10. Ataee P, Afrasiabi V, Nikkhoo B, Sani MN, Rahehagh R, Ghaderi E, et al. Relationship Between Fecal Calprotectin and Upper Endoscopy Findings in Children With Upper Gastrointestinal Symptoms. Iranian Journal of Pediatrics. 2017(In Press).

 11. Campeotto F, Baldassarre M, Butel MJ, Viallon V, Nganzali F, Soulaines P, et al. Fecal Calprotectin: Cutoff Values for Identifying Intestinal Distress in Preterm Infants. J Pediatr Gastroenterol Nutr. 2009;48(4):507-10.

 12. Savino F TV, Lingua C, Moja L, Ricceri F. Pain-relieving agents for infant colic. The Cochrane Library. 2012.

 13. Shahramian I, Moradi M, Afshari M, Delaramnasab M, Sargazi A, Ebrahimi M, et al. Glucose Oral Solution as A Pain-Relieving Agent In Infantile Colic: A Double Blinded Randomized Clinical Trial. International Journal of Pediatrics. 2017;5(12):6529-37.

14. Rhoads JM, Fatheree NY, Norori J, Liu YY, Lucke JF, Tyson JE, et al. Altered Fecal Microflora and Increased Fecal Calprotectin in Infants with Colic. Journal of Pediatrics. 2009;155(6):823-U284.

 15. Rosso C, Caviglia GP, Pellicano R. Usefulness of fecal calprotectin determination in pediatric intestinal diseases. Minerva Pediatrica. 2016;68(6):478-86.

16. Biskou O, Gardner-Medwin J, Mackinder M, Bertz M, Clark C, Svolos V, et al. Faecal Calprotectin in Treated and Untreated Children With Coeliac Disease and Juvenile Idiopathic Arthritis. J Pediatr Gastroenterol Nutr. 2016;63(5):E112-E5.

17. Kapel N, Campeotto F, Kalach N, Baldassare M, Butel MJ, Dupont C. Faecal Calprotectin in Term and Preterm Neonates. J Pediatr Gastroenterol Nutr. 2010;51(5):542-7.

18. Josefsson S, Bunn TK, Domellof M. Fecal calprotectin in very low birth weight infants. J Pediatr Gastroenterol Nutr. 2007;44(4):407-13. 19. Domellof M. Fecal calprotectin: An indicator of NEC in VLBW infants? Pediatric Research. 2004;56(3):476-.

 20. Lee YM, Min CY, Choi YJ, Jeong SJ. Delivery and feeding mode affects fecal calprotectin levels in infants < 7 months old. Early Human Development. 2017;108:45-8.

21. Li F, Ma JQ, Geng SS, Wang JL, Ren F, Sheng XY. Comparison of the different kinds of feeding on the level of fecal calprotectin. Early Human Development. 2014;90(9):471-5.

 22. Polycarpou E, Zachaki S, Papaevangelou V, Tsolia M, Kyriacou A, Kostalos C, et al. Oral L-arginine supplementation and faecal calprotectin levels in very low birth weight neonates. Journal of Perinatology. 2013;33(2):141-6.

23. Savino F, Castagno E, Calabrese R, Viola S, Oggero R, Miniero R. High Faecal Calprotectin Levels in Healthy, Exclusively Breast-Fed Infants. Neonatology. 2010; 97(4):299-304.

24. Dorosko SM, MacKenzie T, Connor RI. Fecal Calprotectin Concentrations Are Higher in Exclusively Breastfed Infants Compared to Those Who Are Mixed-Fed. Breastfeeding Medicine. 2008;3(2): 117-U25.

25. Moussa R, Khashana A, Kamel N, Eisharqawy SE. Fecal calprotectin levels in preterm infants with and without feeding intolerance. Jornal De Pediatria. 2016;92(5):486-92.

26. Heida A, Holtman GA, Lisman-van Leeuwen Y, Berger MY, van Rheenen PF. Avoid Endoscopy in Children With Suspected Inflammatory Bowel Disease Who Have Normal Calprotectin Levels. J Pediatr Gastroenterol Nutr. 2016;62(1):47-9.

27. Bukulmez A, Dogru O, Kundak AA, Oztekin O, Koken R, Melek H, et al. The Effect of Phototherapy on Fecal Calprotectin Levels. American Journal of Perinatology. 2013;30(3):215-8.

28. Oswari H, Prayitno L, Dwipoerwantoro PG, Firmansyah A, Makrides M, Lawley B, et al. Comparison of stool microbiota compositions, stool alpha1-antitrypsin and calprotectin concentrations, and diarrhoeal morbidity of Indonesian infants fed breast milk or probiotic/prebiotic-supplemented formula. Journal of Paediatrics and Child Health. 2013;49(12):1032-9.

29. Ho TTB, Groer MW, Luciano AA, Schwartz A, Ji M, Miladinovic BS, et al. Red blood cell transfusions increase fecal calprotectin levels in premature infants. Journal of Perinatology. 2015;35(10):837-41.

 30. Indrio F, Baldassarre ME, Francavilla R, Marucco AC, Menolascina A, Polimeno L, et al. Effect of unconjugated bilirubin on intestinal permeability and fecal calprotectin in healthy term newborns. Pediatric Research. 2005;58(2):375-.

31. Kolho KL, Alfthan H, Hamalainen E. Effect of Bowel Cleansing for Colonoscopy on Fecal Calprotectin Levels in Pediatric Patients. J Pediatr Gastroenterol Nutr. 2012;55(6):751-3.